|
| |
| | | 68513 | | 22.06.2022 | | iQone Healthcare Switzerland SA | | | | | | | 21.06.2027 | | | | | | | | 07.02.2023 | | 07.15. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Yuflyma 40 mg | solution injectable en seringue préremplie | solution injectable en seringue préremplie (Adalimumab 40mg / 0.4ml) | L04AB04 | |
|
|
|
